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Abstract 
Introduction: Pseudomonas aeruginosa is one of the most common nosocomial pathogens. The emergence of extended spectrum 
β-lactamases (ESBLs) has been increasingly reported as a major clinical concern worldwide. The main aim of the present 
study was to determine the distribution of blaOXA, blaPER-1, blaVEB-1, and blaGES-1 genes among ESBL-producing P. aeruginosa 
isolated from two distinct provinces in Iran. Methods: In this study, a total of 75 (27.5%) ESBL-producing isolates were 
identified from 273 P. aeruginosa isolates collected from patients in Qazvin and Tehran. Phenotypic detection of ESBLs and 
antimicrobial susceptibility testing were performed according to the Clinical and Laboratory Standards Institute guidelines. PCR 
and sequencing were employed to detect bla
OXA-1
, blaOXA, blaGES-1, blaPER-1, and blaVEB-1 genes. Isolate genetic relationships were 
evaluated by repetitive extragenic palindromic sequence-based PCR (REP-PCR). Results: In total, 59 (78.7%) of the ESBL-
producing isolates showed multidrug resistance. The highest rates of susceptibility were observed against colistin (75 isolates, 
100%) and polymyxin B (75, 100%) followed by amikacin (44, 58.7%), and piperacillin-tazobactam (40, 53.3%). The bla
OXA-1 
(37.3%) gene was the most common of the genes investigated, followed by bla
OXA-4 
(32%), bla
GES-1 
(16%), and bla
VEB-1 
(13.3%). 
REP-PCR identified three different genotypes: types A (89.3%), B (6.7%), and C (4%). Conclusions: We found a significant 
presence of bla
OXA-1
, bla
OXA-4
, bla
GES-1, 
and bla
VEB-1
 genes among P. aeruginosa isolates, highlighting the need for suitable infection 
control strategies to effectively treat patients and prevent the further distribution of these resistant organisms. 
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INTRODUCTION
Pseudomonas aeruginosa is the most frequent bacterial 
species associated with infections such as urinary tract 
infections, respiratory infections, dermatitis, soft tissue 
infections, gastrointestinal infections, and a variety of systemic 
infections, particularly in patients with severe burns, cancer, 
and acquired immunodeficiency syndrome (AIDS)1,2. Infections 
caused by P. aeruginosa develop intrinsically and may exhibit 
acquired resistance against various commonly prescribed 
antimicrobial drugs. In addition, infections caused by this 
organism are often difficult to treat, as they eventually reveal 
the emergence of multi-drug resistant Pseudomonas aeruginosa 
(MDRPA) isolates3. Nosocomial infection with MDRPA is 
a serious growing concern worldwide and is associated with 
higher morbidity, mortality, and cost of therapy4. 
There are several mechanisms for the emergence of resistance 
to β-lactam antibiotics, with extended-spectrum β-lactamases 
(ESBLs) among the leading causes5,6. These enzymes are 
plasmid-encoded β-lactamases commonly found in Klebsiella 
pneumoniae and Escherichia coli and also observed in other 
clinical isolates of Enterobacteriaceae and Pseudomonas7-9. It 
is clear that the TEM (temoniera), SHV (sulfhydryl-variable), 
and CTX-M (cefotaximase) proteins are the principal types of 
ESBLs among clinically important Enterobacteriaceae species; 
however, the presence of less-studied types of ESBLs, including 
OXA (oxacillinase), VEB (Vietnamese extended spectrum 
β-lactamase), PER (Pseudomonas extended resistant), and GES 
(Guyana extended spectrum β-lactamase), has been reported in 
other bacterial species10,11. Recent studies have indicated that 
the dissemination of genes that encode ESBLs may play an 
important role in the spread of antibiotic resistance and may 
complicate the treatment of infections caused by P. aeruginosa 
